Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study-Reference-Cited by-同舟云学术

Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study

Published:2019-01-04 Issue:7 Volume:78 Page:1007-1010
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Scherlinger Marc^ORCID,Carcaud Claire,Truchetet Marie-Elise,Barnetche Thomas,Duffau Pierre,Couzi Lionel,Seneschal Julien,Blanco Patrick,Lazaro Estibaliz,Richez Christophe

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference9 articles.

1. Biotherapies in systemic lupus erythematosus: new targets;Lazaro;Joint Bone Spine,2017

2. Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

3. Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review;Contis;Clin Rheumatol,2016

4. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

5. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update;Seminars in Arthritis and Rheumatism;2024-04

2. CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses;Nature Communications;2024-01-29

3. Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review;Frontiers in Medicine;2023-05-25

4. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs;Rheumatology;2020-12

5. Learning From Success and Failure: Biologics for Non-approved Skin Diseases;Frontiers in Immunology;2019-08-08